NCT05789901

The MARVIN Chatbots to Provide Information for Different Health Conditions

A Master Research Protocol to Adapt and Evaluate an Artificial Intelligence Based Conversational Agent to Provide Information for Different Health Conditions: the MARVIN Chatbots

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 400 (estimated)
• Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
• Sex: All
• Age: 14 Years
• Healthy volunteers: Accepted

Summary

This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.

Detailed description

From 2020, the Principal Investigator's team has developed an innovative chatbot named Minimal AntiretRoViral INterference (MARVIN), for people with HIV. The primary objectives with this master protocol are to: 1) develop or adapt the MARVIN chatbots for different healthcare contexts through co-construction; 2) evaluate the global usability of individual chatbots in their respective use scenarios with a small sample of research participants; 3) evaluate the implementation and user outcomes (e.g., fidelity, appropriateness) of individual chatbots in their respective use scenarios with a larger sample of research participants. This includes also documentation of factors that inhibit or enhance the utilization of the chatbots and outcomes; and 4) establish and evaluate, through the previous objectives, different partnerships with research participants and research team members to co-construct chatbots that will respond to their needs and encourage continued use of the tool.

Conditions

• HIV Infections
• Breast Cancer
• Pediatric Emergency Medicine

Interventions

Type	Name	Description
OTHER	MARVIN	Chatbot on Meta (Facebook) Messenger for HIV Patients
OTHER	MARVIN-Pharma	Chatbot on Meta (Facebook) Messenger for community pharmacists
OTHER	MARVINA	Chatbot on Meta (Facebook) Messenger for breast cancer patients
OTHER	MARVIN-CHAMP	CHatbot to Assist the Management of Pediatric patients with infectious conditions (CHAMP)

Timeline

• Start date: 2024-03-01
• Primary completion: 2033-12-31
• Completion: 2034-12-31
• First posted: 2023-03-29
• Last updated: 2024-03-06

Locations

2 sites across 1 country: Canada